As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035
Catalyst Pharmaceuticals Announces Settlement of FIRDAPSE® (amifampridine) Patent Litigation with Lupin Pharmaceuticals
Seeking Alpha / 18 hours ago 4 Views
As Part of the Settlement, Lupin Receives a License to Market Generic FIRDAPSE Beginning in February 2035
Comments